Immune escape mutants of highly pathogenic avian influenza H5N1 selected using polyclonal sera: Identification of key amino acids in the HA protein

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sitaras, Ioannis ^a   Kalthoff, Donata ^b   Beer, Martin ^b   Peeters, Ben ^b   De Jong, Mart C M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; AMINO ACID; ANTISERUM;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGENICITY; ARTICLE; CHICKEN; CONTROLLED STUDY; EMBRYO; ERYTHROCYTE; IMMUNE EVASION; IN VITRO STUDY; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; SERUM; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS MUTATION; AMINO ACID SEQUENCE; ANIMAL; AVIAN INFLUENZA; BIRD; EPIDEMIC; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION; PROCEDURES; VACCINATION; VIROLOGY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS; ANIMALS; BIRDS; DISEASE OUTBREAKS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNE SERA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; MOLECULAR SEQUENCE DATA; MUTATION; VACCINATION;

EID: 84897806429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084628     Document Type: Article

References (77)

1. Alexander DJ (2000) A review of avian influenza in different bird species. Vet Microbiol 74: 3-13.
2. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al. (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79: 2814-2822. (Pubitemid 40270559)
3. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
4. Wan H, Sorrell EM, Song H, Hossain MJ, Ramirez-Nieto G, et al. (2008) Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One 3: e2923.
5. Gerhard W, Webster RG (1978) Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med 148: 383-392. (Pubitemid 8392703)
6. Chakrabarti AK, Pawar SD, Cherian SS, Koratkar SS, Jadhav SM, et al. (2009) Characterization of the influenza A H5N1 viruses of the 2008-09 outbreaks in India reveals a third introduction and possible endemicity. PLoS One 4: e7846.
7. Matrosovich M, Zhou N, Kawaoka Y, Webster R (1999) The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 73: 1146-1155. (Pubitemid 29036766)
8. Ubol S, Suksatu A, Modhiran N, Sangma C, Thitithanyanont A, et al. (2011) Intra-host diversities of the receptor-binding domain of stork faeces-derived avian H5N1 viruses and its significance as predicted by molecular dynamic simulation. J Gen Virol 92: 307-314.
9. Webster RG, Laver WG, Air GM, Schild GC (1982) Molecular mechanisms of variation in influenza viruses. Nature 296: 115-121. (Pubitemid 12160907)
10. Wilson IA, Cox NJ (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8: 737-771. (Pubitemid 20135645)
11. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, et al. (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312: 404-410.
12. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205.
13. Hafez MH, Arafa A, Abdelwhab EM, Selim A, Khoulosy SG, et al. (2010) Avian influenza H5N1 virus infections in vaccinated commercial and backyard poultry in Egypt. Poult Sci 89: 1609-1613.
14. Bouvier NM, Palese P (2008) The biology of influenza viruses. Vaccine 26 Suppl 4: D49-53.
15. Van Borm S, Ferreira HL, van den Berg T (2010) Fine quantification of avian influenza H5N1 escape mutant quasispecies populations using mutation-specific real-time PCR. Avian Dis 54: 558-564.
16. Domingo E (1997) RNA virus evolution, population dynamics, and nutritional status. Biol Trace Elem Res 56: 23-30.
17. Duarte EA, Novella IS, Weaver SC, Domingo E, Wain-Hobson S, et al. (1994) RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis 3: 201-214. (Pubitemid 24288705)
18. Drake JW (1999) The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes. Ann N Y Acad Sci 870: 100-107.
19. Eigen M (1993) Viral quasispecies. Sci Am 269: 42-49.
20. UN FAO (2012) H5N1 HPAI Global Overview January-March 2012.
21. WHO (2011) Avian Influenza Fact Sheet.
22. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, et al. (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353: 1374-1385. (Pubitemid 41362705)
23. Cinatl J Jr., Michaelis M, Doerr HW (2007) The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Med Microbiol Immunol 196: 181-190. (Pubitemid 350105921)
24. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, et al. (2004) Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430: 209-213. (Pubitemid 38902429)
25. Medina RA, Garcia-Sastre A (2011) Influenza A viruses: new research developments. Nat Rev Microbiol 9: 590-603.
26. Webster RG, Peiris M, Chen H, Guan Y (2006) H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 12: 3-8. (Pubitemid 43143527)
27. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, et al. (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336: 1534-1541.
28. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420-428.
29. Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, et al. (2012) The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336: 1541-1547.
30. Nishiura H, Yen HL, Cowling BJ (2013) Sample size considerations for one-to-one animal transmission studies of the influenza A viruses. PLoS One 8: e55358.
31. Swayne DE (2012) Impact of vaccines and vaccination on global control of avian influenza. Avian Dis 56: 818-828.
32. Swayne DE (2012) The role of vaccines and vaccination in high pathogenicity avian influenza control and eradication. Expert Rev Vaccines 11: 877-880.
33. Pavade G, Awada L, Hamilton K, Swayne DE (2011) The influence of economic indicators, poultry density and the performance of veterinary services on the control of high-pathogenicity avian influenza in poultry. Rev Sci Tech 30: 661-671.
34. Swayne DE, Pavade G, Hamilton K, Vallat B, Miyagishima K (2011) Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Rev Sci Tech 30: 839-870.
35. Grund C, Abdelwhab el SM, Arafa AS, Ziller M, Hassan MK, et al. (2011) Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 29: 5567-5573.
36. Kaverin NV, Rudneva IA, Ilyushina NA, Varich NL, Lipatov AS, et al. (2002) Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol 83: 2497-2505.
37. Kaverin NV, Rudneva IA, Ilyushina NA, Lipatov AS, Krauss S, et al. (2004) Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants. J Virol 78: 240-249. (Pubitemid 37549736)
38. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, et al. (2007) Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81: 12911-12917. (Pubitemid 350156928)
39. Gitelman AK, Kaverin NV, Kharitonenkov IG, Rudneva IA, Sklyanskaya EL, et al. (1986) Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol 67 (Pt 10): 2247-2251. (Pubitemid 16026806)
40. Philpott M, Easterday BC, Hinshaw VS (1989) Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity. J Virol 63: 3453-3458. (Pubitemid 19181406)
41. Tsuchiya E, Sugawara K, Hongo S, Matsuzaki Y, Muraki Y, et al. (2002) Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J Gen Virol 83: 1137-1146. (Pubitemid 34477287)
42. Yewdell JW, Caton AJ, Gerhard W (1986) Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol 57: 623-628. (Pubitemid 16147868)
43. Lambkin R, McLain L, Jones SE, Aldridge SL, Dimmock NJ (1994) Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. J Gen Virol 75 (Pt 12): 3493-3502.
44. Archetti I, Horsfall FL Jr. (1950) Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J Exp Med 92: 441-462.
45. Lee CW, Senne DA, Suarez DL (2004) Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78: 8372-8381. (Pubitemid 38944321)
46. Cattoli G, Milani A, Temperton N, Zecchin B, Buratin A, et al. (2011) Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol 85: 8718-8724.
47. Park KJ, Kwon HI, Song MS, Pascua PN, Baek YH, et al. (2011) Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J Gen Virol 92: 36-50.
48. Donald HB, Isaacs A (1954) Counts of influenza virus particles. J Gen Microbiol 10: 457-464.
49. UN OIE (2012) Manual of Diagnostic Tests and Vaccines For Terrestrial Animals (Mammals, Birds and Bees). 7th Edition ed.
50. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376. (Pubitemid 38938148)
51. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Jones TC, et al. (2004) Mutations, drift, and the influenza archipelago. Discov Med 4: 371-377.
52. Fouchier RA, Smith DJ (2010) Use of antigenic cartography in vaccine seed strain selection. Avian Dis 54: 220-223.
53. Cai Z, Zhang T, Wan XF (2010) A computational framework for influenza antigenic cartography. PLoS Comput Biol 6: e1000949.
54. Hoper D, Kalthoff D, Hoffmann B, Beer M (2012) Highly pathogenic avian influenza virus subtype H5N1 escaping neutralization: more than HA variation. J Virol 86: 1394-1404.
55. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, et al. (2009) Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
56. Tamura K, Nei M (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10: 512-526. (Pubitemid 23157236)
57. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
58. Duvvuri VR, Duvvuri B, Cuff WR, Wu GE, Wu J (2009) Role of positive selection pressure on the evolution of H5N1 hemagglutinin. Genomics Proteomics Bioinformatics 7: 47-56.
59. Shih AC, Hsiao TC, Ho MS, Li WH (2007) Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A 104: 6283-6288. (Pubitemid 47186086)
60. Wu WL, Chen Y, Wang P, Song W, Lau SY, et al. (2008) Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 82: 1798-1807. (Pubitemid 351222435)
61. Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276: 172-174.
62. Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Daidoji T, et al. (2012) Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt. J Gen Virol 93: 2215-2226.
63. Arafa A, Suarez D, Kholosy SG, Hassan MK, Nasef S, et al. (2012) Evolution of highly pathogenic avian influenza H5N1 viruses in Egypt indicating progressive adaptation. Arch Virol 157: 1931-1947.
64. Abdelwhab EM, Arafa AS, Stech J, Grund C, Stech O, et al. (2012) Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011. Virus Genes 45: 14-23.
65. Siddique N, Naeem K, Abbas MA, Ahmed Z, Malik SA (2012) Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan reveals genetic diversity. Virol J 9: 300.
66. Jiang WM, Liu S, Chen J, Hou GY, Li JP, et al. (2010) Molecular epidemiological surveys of H5 subtype highly pathogenic avian influenza viruses in poultry in China during 2007-2009. J Gen Virol 91: 2491-2496.
67. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, et al. (2006) Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444: 378-382. (Pubitemid 44764114)
68. Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, et al. (2012) Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J Virol 86: 121-127.
69. Piralla A, Pariani E, Rovida F, Campanini G, Muzzi A, et al. (2011) Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic. PLoS One 6: e28332.
70. Dapat IC, Dapat C, Baranovich T, Suzuki Y, Kondo H, et al. (2012) Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan. PLoS One 7: e36455.
71. Graham M, Liang B, Van Domselaar G, Bastien N, Beaudoin C, et al. (2011) Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009. PLoS One 6: e16087.
72. Kao CL, Chan TC, Tsai CH, Chu KY, Chuang SF, et al. (2012) Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One 7: e31162.
73. ECDC (2011) Surveillance Report: Influenza Virus Characterisation. Summary Europe, February 2011.
74. Portuguese Laboratory Network for the Diagnosis of Influenza I (2012) Contribution of the Portuguese Laboratory Network for the Diagnosis of Influenza A(H1N1)pdm09 infection during the 2009/10 and 2010/11 influenza seasons. Euro Surveill 17.
75. Ilyushina NA, Bovin NV, Webster RG (2012) Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium. J Virol 86: 4724-4733.
76. Sun S, Wang Q, Zhao F, Chen W, Li Z (2011) Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS One 6: e22844.
77. Igarashi M, Ito K, Kida H, Takada A (2008) Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 376: 323-329.